Anzeige
Erschienen in:
01.12.2019 | Stomach and Duodenum (J Pisegna and J Benhammou, Section Editors)
EUS-Guided Portal Venous Sampling of Circulating Tumor Cells
Erschienen in: Current Gastroenterology Reports | Ausgabe 12/2019
Einloggen, um Zugang zu erhaltenAbstract
Purpose of Review
Although liquid biopsies hold significant promise in the management of patients with cancer, peripheral blood analyses remain dependent on the degree of tumor burden with prohibitively low yields until the cancer is widely metastatic. Multiple lines of evidence support a dynamic, spatiotemporal localization of circulating tumor cells (CTCs) supporting specific targeting of vascular compartments, such as the portal vein. This review discusses the literature evaluating the possibility of portal venous blood as a new, potentially higher yield liquid biopsy and the current devices and techniques for endoscopic ultrasound (EUS)-guided portal venous sampling for CTC detection.
Recent Findings
Two recent studies in pancreatic cancer have demonstrated that portal venous blood can be safely sampled via EUS and consistently yields significantly higher CTC counts compared with matched peripheral blood. EUS-acquired samples can be used for molecular testing, clinical prognostication, and drug sensitivity analyses.
Summary
Portal venous CTCs are identified in higher quantity relative to peripheral blood and can be safely obtained via EUS. Further studies are required to demonstrate the clinical utility of EUS-guided portal venous tumor material enrichment and analysis; however, obtaining EUS-guided “liquid biopsies” appears to merit significant consideration for procedural adoption.